Fundz
Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →

Apotex acquires Talicia from RedHill for $18M

PRIVATEAug 31, 20268 days ago

Acquiring Company

Apotex Health

Acquired Company

RedHill Biopharma Ltd

TorontoRaleighManufacturingBiotechnologyHealthcareSoftwareHealth CareScience And Engineering

Description

RedHill Biopharma Ltd. has divested its Talicia business to Apotex Health Corp. for an upfront payment of $18 million, alongside additional milestone payments of up to $35 million. This strategic move allows RedHill to enhance its liquidity and focus on new product opportunities. Apotex aims to expand Talicia's global reach as part of its growth strategy.

Company Information

Company

Apotex Health

Location

Toronto, Ontario, Canada

About

Apotex Health Corp. is one of Canada’s largest pharmaceutical companies. The company specializes in the generics pharmaceutical market and has a significant presence across the Americas and India. With a strong focus on innovation, Apotex aims to expand its specialty drug portfolio.

Don't miss Apotex Health's next move

Get an email the moment Apotex Health makes an acquisition, hires an exec, or expands, usually minutes after it happens.

One email per event. Unsubscribe anytime.

Related People

Alma
Senior decision-maker at this company
••••••••@••••••••

See Alma's verified email →

Vaibhav
Senior decision-maker at this company
••••••••@••••••••

See Vaibhav's verified email →

Predictive Intelligence
Strategic

ML-powered predictions for Apotex Health's next move

Learn about Strategic plan

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Frequently asked

Who acquired RedHill Biopharma Ltd?

RedHill Biopharma Ltd was acquired by Apotex Health, based in Toronto. The deal was reported on August 31, 2026. Apotex Health Corp. is one of Canada’s largest pharmaceutical companies. The company specializes in the generics pharmaceutical market and has a significant presence across the Americas and India. Apotex Health is privately held.

When did Apotex Health acquire RedHill Biopharma Ltd?

Apotex Health's acquisition of RedHill Biopharma Ltd was reported on August 31, 2026. RedHill Biopharma Ltd. has divested its Talicia business to Apotex Health Corp. for an upfront payment of $18 million, alongside additional milestone payments of up to $35 million. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does RedHill Biopharma Ltd do?

RedHill Biopharma Ltd. (Nasdaq: RDHL) is a specialty biopharmaceutical company focused on developing and commercializing therapies for gastrointestinal, infectious, and oncological diseases in the U.S. It is publicly traded (RDHL), operating in Manufacturing, and is based in Raleigh.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.